1. Home
  2. ESCA vs EDIT Comparison

ESCA vs EDIT Comparison

Compare ESCA & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Escalade Incorporated

ESCA

Escalade Incorporated

HOLD

Current Price

$17.62

Market Cap

249.4M

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.93

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESCA
EDIT
Founded
1922
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.4M
206.0M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
ESCA
EDIT
Price
$17.62
$2.93
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$4.92
AVG Volume (30 Days)
45.1K
1.4M
Earning Date
05-04-2026
05-11-2026
Dividend Yield
3.47%
N/A
EPS Growth
6.45
37.50
EPS
0.99
N/A
Revenue
$180,541,000.00
$31,937,000.00
Revenue This Year
$4.15
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.77
N/A
Revenue Growth
2.71
132.64
52 Week Low
$11.41
$1.18
52 Week High
$18.61
$4.54

Technical Indicators

Market Signals
Indicator
ESCA
EDIT
Relative Strength Index (RSI) 57.19 70.86
Support Level $16.77 $2.42
Resistance Level $18.53 $3.17
Average True Range (ATR) 0.76 0.18
MACD -0.12 0.04
Stochastic Oscillator 51.63 98.15

Price Performance

Historical Comparison
ESCA
EDIT

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are the United States, Canada, Australia, and Other regions.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: